News 15-Strain Therapy Matches FMT for C. diff UK Trial A phase 1b trial finds MTC01, a 15-strain live biotherapeutic, matches FMT in treating recurrent C. difficile, with similar gut microbiome engraftment.
News Microbiotica MB097 Shows Promise in Melanoma Trial Microbiotica reports positive Phase 1b data for MB097, a precision microbiome co-therapy combined with pembrolizumab in advanced melanoma patients.
News SER-603 IBD Microbiome Drug: New Preclinical Data Seres Therapeutics presents preclinical data on SER-603, a microbiome-targeting live biotherapeutic for IBD, at DDW 2026. Relevant to UK gut health research.
